Variations in the processing of prostatic needle cores in the UK; what is safe?

Journal of Clinical Pathology

Volumn 56, Issue 5, 2003, Pages 341-343

  Biedrzycki, O ^a   Varma, M ^b   Berney, D M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST; IMMUNOCHEMISTRY; LABORATORY; PATHOLOGY; PRIORITY JOURNAL; PROSTATIC NEEDLE CORE; QUESTIONNAIRE; STANDARD; TECHNIQUE; UNITED KINGDOM; WORKLOAD;

BIOPSY, NEEDLE; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; MALE; PATHOLOGY DEPARTMENT, HOSPITAL; PRACTICE GUIDELINES; PROFESSIONAL PRACTICE; PROSTATE; PROSTATIC NEOPLASMS; SPECIMEN HANDLING; WORKLOAD;

EID: 0038670686     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.5.341     Document Type: Article

References (12)

1. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4.
2. Taylor JA, 3rd, Gancarczyk K, Fant GV, et al. Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer. Urology 2002;60:841-5.
3. Renshaw AA. Adequate tissue sampling of prostate needle core biopsies. Am J Clin Pathol 1997;107:26-9.
4. Thorson P, Vollmer RT, Arcangeli C, et al. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol 1998;11:543-51.
5. Lane RB, Lane CG, Mangold KA, et al. Needle biopsies of the prostate: what constitutes adequate histologic sampling? Arch Pathol Lab Med 1998;122:833-5.
6. Brat DJ, Willis ML, Lecksell KL, et al. How often are diagnostic features missed with less extensive histological sampling of prostate needle biopsy specimens? Am J Surg Pathol 1999;23:257-62.
7. Shaw EB, Daniel BW, Wofford ED, et al. Prostate biopsies: optimized cancer detection and staging. J S C Med Assoc 1996;92:251-66.
8. True LD. Surgical pathology examination of the prostate gland: practice survey by the American Society of Clinical Pathologists. Am J Clin Pathol 1994;102:572-9.
9. Reyes AO, Humphrey PA. Diagnostic effect of complete histologic sampling of prostate needle core biopsy specimens. Am J Clin Pathol 1998;109:416-22.
10. Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate carcinoma. A review of 228 cases. Am J Surg Pathol 1995;19:251-60.
11. Stroumbakis N, Cookson MS, Reuter VE, et al. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology 1997;49(suppl 3A):113-18.
12. Dardik M, Epstein JI. Efficacy of re-staining prostate needle biopsies with high-molecular weight cytokeratin. Hum Pathol 2000;31:1009-10.